In addition, nicotine administration reduces motor symptoms and mitigates the side effects of L-dopa therapy [76], such as dyskinesia, by modulating dopamine release through α7-nAChR activity [77]. The gene discussed is CHRNA7; the disease is drug-induced dyskinesia.